期刊
BLOOD CELLS MOLECULES AND DISEASES
卷 49, 期 3-4, 页码 136-139出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bcmd.2012.06.001
关键词
Thalassemia intermedia; Iron; Chelation; Liver; Fibrosis
类别
资金
- Novartis
Despite evidence of considerable iron overload in transfusion-independent patients with beta-thalassemia intermedia, data on hepatic outcomes remain scarce. We analyzed data from a cohort of 42 beta-thalassemia intermedia adults followed for four years (median age 38 years), and evaluated the association between longitudinal changes in serum ferritin levels and transient elastography values, a measure of hepatic stiffness predictive of fibrosis. We observed a significant increase in both serum ferritin levels (+81.2 [mu g/l]/year) and transient elastography values in non-chelated patients (n = 28) (+0.3 kPa/year), with two patients worsening their fibrosis stage. Chelated patients (n = 14) had a significant decrease in both measures (-42.0 [mu g/l]/year and -0.9 kPa/year, respectively), with two patients improving their fibrosis stage. There was a strong correlation between the rate of change in serum ferritin level and the rate of change in transient elastography value (R-2: 0.836, p<0.001) noted in both non-chelated and chelated patients. An association between iron overload status and hepatic disease merits further evaluation in this subset of transfusion-independent patients. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据